Product Design, Manufacturing & Innovation Resources

Neueste Veröffentlichungen und Patente im Bereich der regenerativen Medizin

Regenerative Medizin

Tipp: Zusätzlich zu der unten stehenden Auswahl können Sie unsere 2 gesamten Datenbanken durchsuchen und filtern:

> Kostenloses Tool zur Suche nach Veröffentlichungen < nach Autor, Thema, Stichwörtern, Datum oder Zeitschrift.

> Kostenloses Tool zur Suche nach Patenten < für Patente in englischer Sprache vom Europäischen Patentamt.

Regenerative Medizin
Die regenerative Medizin integriert Stammzellbiologie, Gewebezüchtung und Biomaterialien, um die Wiederherstellung von Gewebe und Organen zu innovieren.

Regenerative medicine focuses on restoring or replacing damaged tissues and organs through the integration of stem cell biology, tissue engineering, and biomaterials science. This interdisciplinary field employs techniques such as scaffold fabrication, cellular reprogramming, and gene editing to promote tissue regeneration, enhance wound healing, and develop functional organ substitutes. Research addresses cellular differentiation, immunomodulation, vascularization, and extracellular matrix remodeling to optimize therapeutic outcomes. Our page compiles the latest peer-reviewed studies and patented technologies advancing regenerative strategies, biomaterial innovations, and clinical applications that redefine approaches to tissue repair and organ replacement.

Dies ist unsere neueste Auswahl an weltweiten Publikationen und Patenten in englischer Sprache zum Thema Regenerative Medizin, klassifiziert und fokussiert auf Stammzellen, Tissue Engineering, Zelltherapie, Biomaterial, Gerüstherstellung, induzierte pluripotente Stammzellen, regenerative Gerüste, extrazelluläre Matrix, Organregeneration, 3D-Bioprinting, Wachstumsfaktoren, mesenchymale Stammzellen, Zelldifferenzierung, Gene Editing, Wundheilung, regeneratives Biomaterial, Zelltransplantation, Immunmodulation, Geweberegeneration, Zellreprogrammierung, bioaktive Moleküle, Vaskularisierung, Regenerationstherapie, autologe Zellen, allogene Zellen, regenerative Implantate, Zellexpansion, Matrixumbau und regenerative Mikroumgebung.

Compositions, systems, and methods related to cell transduction

Patent published on the 2026-10-15 in WO under Ref WO2026217941 by THE UNIV OF NORTH CAROLINA AT CHAPEL HILL [US] (Brudno Yevgeny [us], Mallory Micah [us])

Abstract: Disclosed herein are dry, macroporous biomaterial scaffolds, systems, and methods for enhancing viral transduction of cells, including primary immune cells. The scaffolds comprise an irregular, randomly distributed surface porosity, a liquid absorption rate of at least about 5 μL/min, and a flexible polymeric structure conferred by non-covalent crosslinking or intrinsic polymer chain flexibility. The disclosed scaffolds are suitable for manufacturing genetically engineered cells, including CAR-[...]


Our summary: The content discusses biomaterial scaffolds designed to enhance viral transduction of immune cells. It details the properties of these scaffolds, including porosity and liquid absorption rates. Additionally, it covers methods for controlling vector copy number and principles for developing advanced transduction-enhancing materials.

biomaterials, viral transduction, cell engineering, scaffold design

Patent

Fusion polypeptide, molecular complex, and use thereof

Patent published on the 2026-10-15 in WO under Ref WO2026214391 by SHENZHEN GENOCURY BIOTECH CO LTD [CN] (Huang Ke [cn], Li Yuhang [cn])

Abstract: Provided are a fusion polypeptide, a molecular complex, a viral vector, and a use thereof. The ability of the molecular complex and the viral vector to specifically bind to a receptor of a viral glycoprotein is inhibited. The present invention is suitable for application in gene therapy such as cell therapy.[...]


Our summary: The invention includes a fusion polypeptide and molecular complex that inhibit binding to a viral glycoprotein receptor. It utilizes a viral vector for targeted delivery. This technology is applicable in gene therapy, particularly for cell therapy.

fusion polypeptide, molecular complex, viral vector, gene therapy

Patent

Prediction of car neurotoxicity using network biosignatures

Patent published on the 2026-10-15 in WO under Ref WO2026218003 by SEATTLE CHILDRENS HOSPITAL D/B/A SEATTLE CHILDRENS RESEARCH INST [US] (Smith Stephen Edward Paucha [us])

Abstract: Provided are methods and compositions related to toxicity associated with administration of cell therapy for the treatment of diseases or conditions, e.g., cancer, including methods for use in predicting and treating toxicity. In some embodiments, the toxicity is a neurotoxicity or cytokine release syndrome (CRS), such as severe neurotoxicity or severe CRS. The methods generally involve determining a biosignature comprising of a differential modulation of one or more protein-interactions in a CA[...]


Our summary: The content discusses methods for predicting car neurotoxicity using network biosignatures. It focuses on the differential modulation of protein interactions in CAR-T cells. Additionally, it includes strategies for treating or preventing severe neurotoxicity and cytokine release syndrome.

neurotoxicity, CAR-T cells, biosignature, cytokine release syndrome

Patent

Methods for the preparation of a human decellularized extracellular matrix (decm) as well as liquid compositions and hydrogels thereof

Patent published on the 2026-10-15 in WO under Ref WO2026215533 by BIOMEX GMBH [DE] (Bosnjak Oliver [de], Hermes Monika [de], Bickle Marc [de], Belharazem Djeda [de])

Abstract: The present invention relates to tissue-derived human decellularized extracellular matrix (human dECM) and to methods for producing such human dECM. The invention further relates to a liquid human dECM composition prepared from the human dECM as well as to methods for producing a hydrogel from this liquid composition and methods of preparing a three-dimensional (3D) cell or tissue culture system. Embodiments of the invention have been particularly developed to enable the reproducible preparation[...]


Our summary: The invention describes methods for preparing human decellularized extracellular matrix (dECM) and its liquid compositions. It also details the production of hydrogels from these compositions for use in three-dimensional cell or tissue culture systems. The methods aim for reproducibility across various tissue sources, ensuring broad applicability.

decellularized extracellular matrix, hydrogel, tissue engineering, 3D cell culture

Patent

Isolated olfactory mucosa mesenchymal stem cells and biomaterials thereof for promoting peripheral nerve regeneration

Patent published on the 2026-10-14 in EP under Ref EP4821500 by REQUIMTE REDE DE QUIM E TECNOLOGIA [PT] (Alvites Rui [pt], MaurÍcio Ana [pt], LuÍs Ana [pt], Atayde LuÍs [pt], MendonÇa Carla [pt])

Abstract: The present invention relates to mesenchymal stem cells isolated from the olfactory mucosa (OM-MSCs) and respective secretome (OMS) integrated with biomaterials such as Neural Guide Conduits/Tubes (NGCs) to promote peripheral nerve regeneration.Therefore, it is herein disclosed a process of isolating OM-MSCs and the respective secretome, cell lines, secretome and culturing media for said OM-MSCs and OMS.Also disclosed is a process to obtain biomaterials comprising integrated OM-MSCs and OMS into[...]


Our summary: This invention focuses on isolating mesenchymal stem cells from the olfactory mucosa and their secretome to enhance peripheral nerve regeneration. It describes integrating these cells with biomaterials like Neural Guide Conduits to optimize the regeneration process. The technology aims to improve cellular survival and proliferation in nerve tissue repair.

mesenchymal stem cells, olfactory mucosa, peripheral nerve regeneration, biomaterials

Patent

Hybrid three-dimensional printing and electrospinning platform for multi-layered biomimetic scaffolds

Patent published on the 2026-10-08 in US under Ref US20260306705 by MARSHALL UNIV RESEARCH CORPORATION [US] (Nosoudi Nasim [us], Coffman Gary [us], Cunningham Adam [us])

Abstract: Example embodiments disclose a hybrid three-dimensional (3D) printing and electrospinning system that includes a 3D printer configured to print biomaterial, the 3D printer includes a printer head assembly for extruding a liquid solution that forms the biomaterial via a nozzle, an electrospinning unit for generating electrospin fibers, wherein the printed biomaterials and electrospin fibers are extruded from the same nozzle, and a collection plate for assembling the printed biomaterial and electr[...]


Our summary: The content describes a hybrid system combining 3D printing and electrospinning. It features a printer that extrudes biomaterials and generates electrospun fibers from the same nozzle. The setup includes a collection plate for assembling these components into multi-layered scaffolds.

3D printing, electrospinning, biomimetic scaffolds, hybrid platform

Patent

Gene editing using large insertions

Published on 2026-09-17 by Alexandra Despang @NATURE

Abstract: Nature Biotechnology, Published online: 17 September 2026; doi:10.1038/s41587-026-03319-6While technologies for smaller gene edits, such as base editing, have already entered clinical trials, larger gene cargoes face different challenges, including low editing efficiencies, delivery vehicle size constraints, and possible immunogenicity. Programmable genome engineering systems using recombinases; transposases, including CRISPR-associated transposases (CASTs); genome writing systems; and retrotran[...]


Our summary: The article discusses the challenges of gene editing with large insertions, highlighting issues like low editing efficiencies and delivery constraints. It reviews various programmable genome engineering systems, including recombinases and CRISPR-associated transposases. Experts share insights on strategies to enhance these technologies for therapeutic applications.

gene editing, large insertions, genome engineering, CRISPR

Publication

Joint material and shape optimization of a 3D printing nozzle by CFD and response surface methodology

Published on 2026-03-12 by @OXFORD

Abstract: AbstractThree-dimensional printing (3D printing) has emerged as a transformative technology in medicine, enabling the fabrication of complex structures with high precision. In bioprinting, optimization of nozzle design is essential to balance print resolution, mechanical strength, and biocompatibility. This study presents a computational framework for optimizing bioprinting performance by simultaneously accounting for nozzle geometry and biomaterial rheological properties. Using computational fl[...]


Our summary: This study presents a computational framework for optimizing bioprinting by integrating nozzle geometry and biomaterial properties. It utilizes CFD and response surface methodology to identify optimal nozzle configurations. Results show significant improvements in flow rate and reductions in wall shear stress, demonstrating the effectiveness of the approach.

3D printing, nozzle optimization, computational fluid dynamics, response surface methodology

Publication

Behandelte Themen: Regenerative Medizin, Stammzellbiologie, Tissue Engineering, Biomaterialien, Gerüstherstellung, zelluläre Reprogrammierung, Gen-Editierung, Geweberegeneration, Wundheilung, Organersatz, zelluläre Differenzierung, Immunmodulation, Vaskularisierung, Umbau der extrazellulären Matrix, therapeutische Ergebnisse, begutachtete Studien, klinische Anwendungen, ISO 13485, ISO 14971, ASTM F2633, ISO 10993 und ISO 14644.

Historischer Kontext

1965
1970
1980
1980
1990
1960
1969
1976-05-28
1980
1990

(wenn das Datum unbekannt oder nicht relevant ist, z. B. „Strömungsmechanik“, wird eine gerundete Schätzung seines bemerkenswerten Auftretens bereitgestellt)

10. Jahr Jubiläum

Bilder in voller Größe und Downloads sind nur für registrierte Mitglieder 100% kostenlos verfügbar.

> Login <